VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+6.97%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$78.8M
AUM Growth
+$78.8M
(-31%)
Cap. Flow
-$38.9M
Cap. Flow
% of AUM
-49.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
1
Closed
2
Top Buys
| 1 |
BITI
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
|
$5.37M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$35.8M |
| 2 |
Inogen
INGN
|
$4.97M |
| 3 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
$3.53M |
Sector Composition
| 1 | Healthcare | 83.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
| $35.8M | 45.41% | 407,416 -407,417 | -50% | -$35.8M |
|
|
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $27.1M | 34.41% | 1,092,152 | – | – |
|
|
AKAO
3
DELISTED
Achaogen, Inc.
AKAO
| $7.73M | 9.8% | 1,281,152 | – | – |
|
|
BITI
4
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
| $5.37M | 6.81% | +268,672 | New | +$5.37M |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $2.82M | 3.58% | 1,048,601 | – | – |
|
|
6
Inogen
INGN
$216M
| – | – | -155,284 | Closed | -$4.97M |
|
|
KYTH
7
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| – | – | -70,376 | Closed | -$3.53M |
|